CJC-1295 & Ipamorelin 5mg/10mg

Description

CJC-1295 & Ipamorelin (5mg/10mg Blend) merges two highly researched peptides that work synergistically to stimulate endogenous growth hormone (GH) release. CJC-1295, a GHRH analog, increases the amplitude and duration of GH pulses—especially when formulated with DAC. Ipamorelin, a selective GHRP (Growth Hormone Releasing Peptide), triggers GH release by mimicking ghrelin and acting on the pituitary and hypothalamus without increasing cortisol or prolactin.

Together, this combination is widely studied for its potential to support enhanced muscle recovery, body composition improvement, anti-aging mechanisms, and overall regenerative effects—making it a prominent subject in hormone-related preclinical research.

How CJC-1295 & Ipamorelin Blend Works:

• CJC-1295: Stimulates longer-duration GH pulses via GHRH receptor activation

• Ipamorelin: Triggers GH release through ghrelin mimicry without affecting stress hormones

• Dual-pathway activation enhances GH secretion amplitude and frequency

• Synergistic effect may support more stable and elevated GH levels in research settings

Potential Benefits (Based on Preclinical Research):

• Promotes lean muscle mass and fat metabolism

• Supports joint and tissue recovery

• May improve sleep quality, skin health, and overall regeneration

• Minimal side effects due to selective receptor activity and no impact on cortisol

⚠️ For Research Use Only. Not for Human Consumption.
This compound is not approved by the FDA or any regulatory body and is intended solely for laboratory research.